25 GHP Q4 2022 PolyNovo offers patients around theworld a revolutionary treatment for their wounds. Indeed, specialising insyntheticmaterials for regenerativemedicine,PolyNovo’s innovativeproducts provide a fast and effective solution, easing the pressure on healthcare practitioners. Most Innovative Wound Care Medical Device Company 2022 ounded in response to the aftermath of the 2002 Bali Bombing which saw survivors flown into Australia for treatment, PolyNovo is a medical technology company that endeavours to fill the current gaps in advanced wound care. The company specialises in the design, manufacturing, and distribution of synthetic materials for regenerative medicine, with a specific focus on developing and providing access to the next generation of regenerative medicine technologies that address the numerous challenges that its target clientele faces on a daily basis. PolyNovo’s customer-base is primarily made up of plastic, burn, trauma, general, and vascular surgeons around the world, and it specifically works with clinicians who are managing significant and complex wounds stemming from trauma, burns, necrotizing infections, and non-healing wounds. Such wounds are often lifethreatening, or at the very least, life-changing, and the costs of treating these wounds are significant to patients, healthcare facilities, insurance payers, and society. Simply, PolyNovo is on a mission to provide optimal outcomes and change patient lives for the better. Through developing and commercialising the world’s first synthetic dermal substitute, PolyNovo maintains a clear advantage over current solutions, as its unique technology is effective in fighting against infections, is easy to apply and manage, and is facilitating results that are causing a buzz amongst stakeholders. Moreover, it is supported by 46 patents and has been covered in over 65 peer-reviewed publications, has received Breakthrough Device Designation from the FDA, and is the only dermal substitute funded by the U.S. Biomedical Advanced Research and Development Authority investigating treatment for deep burns. However, this is not the only element that makes the company unique. PolyNovo’s culture is unlike anything else on the contemporary market – for example, whilst it could have priced its products near that of its competition, it opted to make its products affordable in order to boost accessibility on a global scale. PolyNovo prides itself on being inclusive, both in and outside of the workplace, as it empowers its team to do their absolute best for its patients and customers by encouraging staff to bring their best selves to work. As such, PolyNovo has become a company that fosters teamwork and collaboration that drives innovation and subsequently delivers value to all of its stakeholders. The company has achieved great success through this approach, with its product, the NovoSorb BTM, being adopted by clinicians across the globe for the management of traumatic wounds. PolyNovo is in the process of investigating NovoSorb technology’s effectiveness in the treatment of 3rd degree burns, which is being fulfilled in the United States through a pivotal clinical trial. Further, the company is also delving in to testing the use of the technology outside of surgical theatres, as PolyNovo hopes to bring greater access to those suffering from outpatient wounds. Over the past year, PolyNovo grew its U.S. sales by 55% and its global sales by 47.6%, meaning that it is rapidly attracting more customers and providing greater access to its technology. The company also grew internally by 43% to further support its capabilities in driving future international growth. Henceforth, as the company moves into 2023, PolyNovo is seeking to continue to scale globally at a sustainable rate. PolyNovo will be conducting several prospective studies, and it is looking forward to producing more clinical evidence of the benefits its products provide. Contact: Dan King Company: PolyNovo Web Address: www.polynovo.com F Aug22397 Founded in response to the aftermath of the 2002 Bali Bombing which saw survivors flown into Australia for treatment, PolyNovo is a medical technology company that endeavours to fill the current gaps in advanced wound care.
RkJQdWJsaXNoZXIy MTQxNTg3MQ==